98 related articles for article (PubMed ID: 21933235)
1. An eruptive pigmented lesion after melanotan injection.
Ferrándiz-Pulido C; Fernández-Figueras MT; Quer A; Ferrándiz C
Clin Exp Dermatol; 2011 Oct; 36(7):801-2. PubMed ID: 21933235
[No Abstract] [Full Text] [Related]
2. Eruptive melanocytic naevi following melanotan injection.
Cousen P; Colver G; Helbling I
Br J Dermatol; 2009 Sep; 161(3):707-8. PubMed ID: 19575725
[No Abstract] [Full Text] [Related]
3. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract][Full Text] [Related]
4. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
Cardones AR; Grichnik JM
Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
[TBL] [Abstract][Full Text] [Related]
5. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
Burian E; Burian E
Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
[No Abstract] [Full Text] [Related]
6. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
[No Abstract] [Full Text] [Related]
7. [Eruptive dysplastic nevi following melanotan use].
Hueso-Gabriel L; Mahiques Santos L; Terrádez Mas L; Santonja López N
Actas Dermosifiliogr; 2012 May; 103(4):329-31. PubMed ID: 22425244
[No Abstract] [Full Text] [Related]
8. [Melanotan-induced lentigines and nevi].
Thestrup-Pedersen K; Søndergaard K
Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
[TBL] [Abstract][Full Text] [Related]
9. Change in moles linked to use of unlicensed "sun tan jab".
Langan EA; Ramlogan D; Jamieson LA; Rhodes LE
BMJ; 2009 Jan; 338():b277. PubMed ID: 19174439
[No Abstract] [Full Text] [Related]
10. Melanotan-associated melanoma.
Paurobally D; Jason F; Dezfoulian B; Nikkels AF
Br J Dermatol; 2011 Jun; 164(6):1403-5. PubMed ID: 21564053
[No Abstract] [Full Text] [Related]
11. Melanotropic peptides: what exactly is meant by "melanotan"?
Langan EA; Rhodes LE
Acta Derm Venereol; 2011 May; 91(3):377; author reply 377-8. PubMed ID: 21547334
[No Abstract] [Full Text] [Related]
12. Melanotan-associated melanoma in situ.
Ong S; Bowling J
Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
[TBL] [Abstract][Full Text] [Related]
13. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals.
Bovenschen HJ; Tjioe M; Vermaat H; de Hoop D; Witteman BM; Janssens RW; Stoof TJ; van de Kerkhof PC
Br J Dermatol; 2006 May; 154(5):880-4. PubMed ID: 16634890
[TBL] [Abstract][Full Text] [Related]
14. Melanotan-associated transverse melanonychia.
Paurobally D; El Hayderi L; Richert B; Andre J; Nikkels AF
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):128-9. PubMed ID: 22182016
[No Abstract] [Full Text] [Related]
15. Consider underlying body dysmorphic disorder in users of melanotan.
Affleck A
Br J Dermatol; 2010 Feb; 162(2):459-60. PubMed ID: 19919633
[No Abstract] [Full Text] [Related]
16. Acral PUVA--induced pigmented macules.
Cruz A; Sánchez JL
Bol Asoc Med P R; 1990 Oct; 82(10):460-2. PubMed ID: 2080960
[TBL] [Abstract][Full Text] [Related]
17. The unregulated use of melanotan-II is of public health interest to Australian dermatologists.
Adler NR; Dowling JP; Pan Y
Australas J Dermatol; 2017 Nov; 58(4):327-329. PubMed ID: 28905366
[No Abstract] [Full Text] [Related]
18. Melanotan and the posterior reversible encephalopathy syndrome.
Kaski D; Stafford N; Mehta A; Jenkins IH; Malhotra P
Ann Intern Med; 2013 May; 158(9):707-8. PubMed ID: 23648958
[No Abstract] [Full Text] [Related]
19. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?
Langan EA; Nie Z; Rhodes LE
Br J Dermatol; 2010 Sep; 163(3):451-5. PubMed ID: 20545686
[TBL] [Abstract][Full Text] [Related]
20. Melanoma, eruptive naevi and natalizumab: Causal relation or coincidence?
Munguía-Calzada P; Vivanco B; Oliva-Nacarino P; Santos-Juanes J
Australas J Dermatol; 2017 Nov; 58(4):330-331. PubMed ID: 28925067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
